leisure time -WSS

leisure time

author：explore 2025-10-01 02:15:55 - browse：1832

Adobe

Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals, and other health care facilities as part of its response to the February 21 Change Healthcare cyberattack.

The payments are meant to fund providers that aren’t able to submit claims to Medicare because of the disruption to Change’s data network and have exhausted all other potential avenues of funding. Medicare will advance up to 30 days of payment, based on the average monthly amount a provider received from Medicare from August 1 to October 31, 2023. The providers are expected to repay the money 90 days after receiving the payment, with interest beginning to accrue 30 days after that.

“We welcome today’s announcement and will continue to work with policymakers as the impacts from the cyberattack persist,” the American Hospital Association said in a statement after the announcement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Illumina names Agilent executive as new CEO

hotspot

knowledge

WSS

House transparency, PBM reform bill gains bipartisan support

Illumina names Agilent executive as new CEO

Cell therapy fails to slow type 1 diabetes, but safety is established

UnitedHealth financials solid despite Change Healthcare cyberattack

NIH nominee Bertagnolli will get October confirmation hearing

After traumatic brain injury, life support decisions can use more time

leisure time

leisure time

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Trump surgeon general acknowledges mistakes during Covid

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

More tobacco lobbyists active in statehouses

Tori Bowie and the unacceptable rates of Black maternal death

Key Senate committee drafts bipartisan bill to stem drug shortages

Supreme Court strikes down use of affirmative action

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

FDA approval of Sarepta Duchenne genetic therapy gives me hope

House transparency, PBM reform bill gains bipartisan support

hotspot

Illumina names Agilent executive as new CEO

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

House transparency, PBM reform bill gains bipartisan support

A new House health package & hospitals’ new site

Medicaid rebukes states for mistakenly disenrolling children

Element Biosciences CEO lays out genome sequencing strategy

focus

hotspot

knowledge

explore